Tricuspid Regurgitation Clinical Trials

41 recruiting

Tricuspid Regurgitation Trials at a Glance

49 actively recruiting trials for tricuspid regurgitation are listed on ClinicalTrialsFinder across 6 cities in 27 countries. The largest study group is Not Applicable with 26 trials, with the heaviest enrollment activity in New York, Portland, and The Bronx. Lead sponsors running tricuspid regurgitation studies include LMU Klinikum, Abbott Medical Devices, and Cardiovalve Ltd..

Browse tricuspid regurgitation trials by phase

Treatments under study

About Tricuspid Regurgitation Clinical Trials

Looking for clinical trials for Tricuspid Regurgitation? There are currently 41 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Tricuspid Regurgitation trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Tricuspid Regurgitation clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 49 trials

Recruiting

Atrial Functional Mitral Regurgitation and Tricuspid Regurgitation

Atrial FibrillationFunctional Mitral RegurgitationFunctional Tricuspid Regurgitation
Barts & The London NHS Trust141 enrolled1 locationNCT05920824
Recruiting

DELINEATE-Prospective

Valvular Heart DiseaseValve Disease, AorticAortic Stenosis+2 more
Columbia University50 enrolled1 locationNCT07197736
Recruiting
Not Applicable

Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

Tricuspid RegurgitationTricuspid Valve InsufficiencyTricuspid Valve Disease
Edwards Lifesciences870 enrolled79 locationsNCT04097145
Recruiting

TriClip Japan Post-Approval Study

Tricuspid Regurgitation
Abbott Medical Devices250 enrolled1 locationNCT07509658
Recruiting
Not Applicable

Robotic Transjugular Transcatheter Tricuspid Valve Replacement

Tricuspid Regurgitation (TR)Transcatheter Valve ReplacementValvular Heart Diseases
Prince of Wales Hospital, Shatin, Hong Kong10 enrolled1 locationNCT07516145
Recruiting
Not Applicable

Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)

Tricuspid RegurgitationTricuspid Valve DiseaseTricuspid Valvular Disorders
VDyne, Inc.30 enrolled11 locationsNCT05848284
Recruiting

Berlin Registry of Right Heart Interventions

Tricuspid RegurgitationPulmonary Regurgitation
Charite University, Berlin, Germany200 enrolled1 locationNCT04570163
Recruiting

Evaluation of the Impact of Interventional Treatments for Symptomatic, Severe Tricuspid Valve Insufficiency on Renal Integrity and Function, as Well as on Physical Function and Activity in Older Adults.

FrailtyTricuspid RegurgitationCardio-Renal Syndrome+1 more
Robert Bosch Medical Center100 enrolled1 locationNCT07464106
Recruiting
Not Applicable

TTVR Early Feasibility Study

Tricuspid Regurgitation
Medtronic Cardiovascular150 enrolled20 locationsNCT04433065
Recruiting
Not Applicable

PA Pressure Monitoring in Patients With Tricuspid Regurgitation

Heart Failure With Severe Tricuspid Regurgitation
LMU Klinikum30 enrolled2 locationsNCT07442903
Recruiting
Not Applicable

A Prospective, Multicenter, Randomized Controlled Clinical Trial of Transcatheter Tricuspid Valve Clipping Systems.

Severe or Greater Tricuspid Regurgitation
Shanghai Huihe Medical Technology Co., Ltd132 enrolled1 locationNCT07433504
Recruiting
Not Applicable

Acute Safety and Efficacy of the Pivot Bridge System for Functional Tricuspid Regurgitation

Tricuspid Regurgitation Functional
Tau-MEDICAL Co., Ltd.20 enrolled4 locationsNCT07385625
Recruiting
Not Applicable

"TARGET 2.0 Study": Safety and Performance of the Cardiovalve TR Replacement System

Tricuspid Regurgitation
Cardiovalve Ltd.150 enrolled2 locationsNCT07334691
Recruiting
Not Applicable

"TARGET Study": Safety and Performance of the Cardiovalve TR Replacement System

Tricuspid Regurgitation
Cardiovalve Ltd.100 enrolled7 locationsNCT05486832
Recruiting
Not Applicable

Band Versus Ring for Tricuspid Regurgitation

Tricuspid Regurgitation
Nanjing Medical University300 enrolled1 locationNCT04093297
Recruiting
Not Applicable

Early Phase Study Using the 'Pivot Extend' System as a Treatment for Patients With Tricuspid Regurgitation

Tricuspid Regurgitation
Tau Medical Australia Pty Ltd10 enrolled1 locationNCT07172477
Recruiting
Not Applicable

Trisol System EFS Study

Tricuspid Regurgitation
Trisol Medical30 enrolled7 locationsNCT04905017
Recruiting
Not Applicable

EFS of the DUO System for Tricuspid Regurgitation

Tricuspid RegurgitationHeart Valve DiseasesTricuspid Valve Insufficiency+1 more
CroiValve Limited15 enrolled16 locationsNCT05913908
Recruiting
Not Applicable

Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation

Tricuspid RegurgitationTricuspid Valve DiseaseTricuspid Valvular Disorders
VDyne, Inc.120 enrolled21 locationsNCT05797519
Recruiting
Not Applicable

Laplace Early Feasibility Study - Canada

Tricuspid Regurgitation
Laplace Interventional, Inc15 enrolled1 locationNCT07171060